Talis Biomedical Corp (TLIS) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 31 transactions totaling $107.0M, demonstrating a bullish sentiment with $106.5M in net insider flow. The most recent transaction on Sep 6, 2024 involved a purchase of 25,000 shares valued at $37.0K.
No significant insider buying has been recorded for TLIS in the recent period.
No significant insider selling has been recorded for TLIS in the recent period.
Based on recent SEC filings, insider sentiment for TLIS is bullish with an Insider Alignment Score of 100/100 and a net flow of $106.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Talis Biomedical Corp (TLIS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading TLIS stock, having executed 31 transactions in the past 90 days. The most active insider is Bros. Advisors (gp) Llc Baker (Executive), who has made 2 transactions totaling $100.0M.
Get notified when executives and directors at TLIS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Michael Leonard Braden | Executive | Purchase | 25,000 | $1.48 | $37.0K | |
| Sep 5, 2024 | Michael Leonard Braden | Executive | Purchase | 5,100 | $1.40 | $7.1K | |
| Sep 3, 2024 | Michael Leonard Braden | Executive | Purchase | 500 | $4.00 | $2.0K | |
| Aug 30, 2024 | Michael Leonard Braden | Executive | Purchase | 151 | $4.25 | $642 | |
| Aug 28, 2024 | Michael Leonard Braden | Executive | Purchase | 1,215 | $3.96 | $4.8K | |
| Aug 26, 2024 | Michael Leonard Braden | Executive | Purchase | 13,167 | $3.90 | $51.4K | |
| Nov 18, 2021 | Advisors Lp Baker Bros. | Executive | Purchase | 50,000 | $4.37 | $218.5K | |
| Aug 13, 2021 | Ramakrishnan Ramesh | Executive | Option Exercise | 43,614 | $1.50 | $65.4K | |
| Aug 13, 2021 | Ramakrishnan Ramesh | Executive | Sale | 27,502 | $7.66 | $210.7K | |
| Aug 13, 2021 | Ramakrishnan Ramesh | Executive | Option Exercise | 8,741 | $1.50 | $13.1K | |
| May 17, 2021 | W. Scott Randal | Executive | Purchase | 11,000 | $10.11 | $111.2K | |
| May 14, 2021 | W. Scott Randal | Executive | Purchase | 9,000 | $10.16 | $91.4K | |
| Feb 17, 2021 | Coe Brian | Executive | Conversion | 7,433 | $N/A | $0 | |
| Feb 17, 2021 | Coe Brian | Executive | Conversion | 8,416 | $N/A | $0 | |
| Feb 17, 2021 | Coe Brian | Executive | Conversion | 15,082 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 18 | $106.7M | 99.7% |
Sale(S) | 1 | $210.7K | 0.2% |
Exercise(M) | 2 | $78.5K | 0.1% |
Conversion(C) | 10 | $0 | 0.0% |
Insiders at Talis Biomedical Corp are accumulating shares at an accelerated pace. With 11 insiders making 31 transactions totaling $106.7M in purchases versus $210.7K in sales, the net buying activity of $106.5M signals strong executive confidence. Bros. Advisors (gp) Llc Baker (Executive) leads the buying activity with $100.0M in transactions across all time.